Eye-tracking test could facilitate earlier Alzheimer's diagnoses
September 18, 2012 in Alzheimer's disease & dementia
With the steady increase in the life expectancy of Europe's population, researchers estimate that the number of people affected by age-related diseases, such as Alzheimer's disease, will increase dramatically in the next few years. This makes improving our understanding of the disease and its early diagnosis an important priority. New research, led by Lancaster University in the United Kingdom, in partnership with Royal Preston Hospital, Lancashire Teaching Hospitals NHS foundation trust, and published in the Journal of the American Aging Association, shows that people with Alzheimer's disease have difficulty with one particular type of eye-tracking test.
That a simple eye-tracking test could hold the key to earlier Alzheimer's diagnosis is an important finding, according to Dr Trevor Crawford from the Department of Psychology and the Centre for Ageing Research, Lancaster University. He noted that these new results were potentially very exciting as they demonstrated, for the first time, a connection with the memory impairment that is so often the first noticeable symptom in Alzheimer's disease.
'The diagnosis of Alzheimer's disease is currently heavily dependent on the results of a series of lengthy neuropsychological tests,' Dr Crawford said. 'However, patients with a dementia often find that these tests are difficult to complete due to a lack of clear understanding and lapse in their attention or motivation.
'Over the last 10 years researchers in laboratories around the world have been working on an alternative approach based on the brain's control of the movements of the eye as a tool for investigating cognitive abilities such as attention, cognitive inhibition and memory.'
In the study, 18 patients with Alzheimer's disease, 25 patients with Parkinson's disease, 17 healthy young people and 18 healthy older people were asked to follow the movements of light on a computer monitor, and in some instances they were asked to look the opposite way, away from the light.
What the research group found were stark contrasts in the eye-tracking measurements taken from the research sample. In particular, patients with Alzheimer's made mistakes on the task where they were asked to look away from the light and were unable correct those errors, despite the fact that they were able to respond perfectly normally when they were asked to look towards the light. These uncorrected errors were 10 times more frequent in the Alzheimer's patients compared to the control groups.
Researchers also measured memory function among those Alzheimer's patients who found the test difficult and were able to show a clear correlation with lower memory function.
'This study takes this work forward because we found strong evidence that the difficulty in noticing and correcting the errors was probably caused by a problem in the memory networks of the brain that allow us to store the spatial position of objects in the environment,' Dr Crawford explained. 'The light tracking test could play a vital role in diagnosis as it allows us to identify, and exclude number alternative explanations of the test results.'
More information: Crawford, T.J., et al. The role of working memory and attentional disengagement on inhibitory control: effects of aging and Alzheimer's disease'. AGE, 2012.
Journal reference:
AGE
Provided by
CORDIS
-
Are the eyes the key to a new test for Alzheimer's disease?
Aug 23, 2012 |
not rated yet |
0
-
Tests may predict driving safety in people with Alzheimer's disease
Feb 09, 2009 |
not rated yet |
0
-
Early-onset Alzheimer's not always associated with memory loss
May 19, 2011 |
not rated yet |
0
-
Blood test for Alzheimer's: Study identifies procedure that detects early stages
May 04, 2011 |
not rated yet |
0
-
Test could detect Alzheimer's disease earlier than previously possible
May 16, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
The Durability of Bone: Long Falls
5 hours ago
-
Is energy convertible to matter?
6 hours ago
-
Rotating electron as a dipole is this right?
9 hours ago
-
Dipole term in multipole expansion
13 hours ago
-
Bubbles in a Pre-Boiling/Boiling pot of water
14 hours ago
-
Assumptions of Griffith's fracture theory
May 21, 2013
- More from Physics Forums - Classical Physics
More news stories
Drugs found to both prevent and treat Alzheimer's disease in mice
Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.
Alzheimer's disease & dementia
12 hours ago |
5 / 5 (6) |
0
|
Scientists identify molecular trigger for Alzheimer's disease
Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease – when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons ...
Alzheimer's disease & dementia
May 20, 2013 |
5 / 5 (4) |
0
|
Study finds that sleep apnea and Alzheimer's are linked
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
Alzheimer's disease & dementia
May 19, 2013 |
5 / 5 (3) |
0
|
Alzheimer's leaves bilingual victims stranded in Canada
The devastating effect of Alzheimer's disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.
Alzheimer's disease & dementia
May 19, 2013 |
not rated yet |
0
Study identifies new approach to improving treatment for MS and other conditions
(Medical Xpress)—Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved ...
Alzheimer's disease & dementia
May 17, 2013 |
5 / 5 (2) |
0
|
If you can remember it, you can remember it wrong
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
Insight into the dazzling impact of insulin in cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
Antidepressant reduces stress-induced heart condition
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.